Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TTC3 antisense RNA 1 (TTC3-AS1)
- Target
- TTC3-AS1
- Molecular classification
- Long non-coding RNA (lncRNA), Natural antisense transcript (NAT), Other (non-protein coding RNA family)
01
Overview
TTC3 antisense RNA 1 (TTC3-AS1) is a long non-coding RNA transcribed in the antisense direction from the TTC3 gene locus. Like other antisense lncRNAs, TTC3-AS1 is thought to regulate gene expression through chromatin remodeling, transcriptional interference, and possibly post-transcriptional modulation of mRNA stability, typically affecting its corresponding sense gene[1][4][5][7]. There are currently no specific links to diseases or known drug interactions, but research in related antisense lncRNAs shows potential involvement in cancer progression and epigenetic regulation[2][7]. TTC3-AS1 is catalogued primarily for its regulatory roles and may have context-specific effects in gene networks, but is not a classical pharmacological target such as a receptor or enzyme[4].
- Other names
- TTC3-AS1TTC3 antisense RNA 1 (non-protein coding)TTC3 antisense RNA 1
02
Mechanism of action
Not applicable; there are no drugs known to target TTC3-AS1
03
Biological functions
Regulation of gene expression, especially of the adjacent TTC3 gene (through transcriptional and post-transcriptional mechanisms, typical of antisense lncRNAs)Potential roles in chromatin remodeling, epigenetic regulation, and mRNA stability (general functions for antisense lncRNAs)
04
Disease associations
Not specifically assigned to major disease categories based on public data. Generally, antisense lncRNAs are implicated in cancer, tumorigenesis, and gene imprinting in various contextsNo specific disease associations for TTC3-AS1 found in current sources
Beyond the preview
Go deeper on TTC3 antisense RNA 1 (TTC3-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TTC3 antisense RNA 1 (TTC3-AS1).